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Immunocytochemistry with a monoclonal antibody against the GABAA/benzodiazepine receptor showed labeled axo-dendritic synapses in 
the anteroventral cochlear nucleus. In the dorsal cochlear nucleus, label was seen apposing both axo-somatic and axo-dendritic terminals. The 
results suggest a heterogeneous distribution of GABA receptors, together with a possible segregation of receptor subtypes between somata 
and dendrites in certain neurons. The presence of cytoplasmic labeling in some neurons might reflect a higher receptor turnover rate in these 
neurons. 
Many studies indicate that 3,-aminobutyric acid 
(GABA) is an important neurotransmitter mediating 
inhibition in the cochlear nucleus (CN) (for review see 
refs. 7, 58). GABA and glutamic acid decarboxylase 
(GAD) levels are high in the cochlear nucleus 12"ls'l~'62, 
particularly in the dorsal CN 15. GABA and GAD have 
been localized immunocytochemically in cells, fibers and 
terminals in the CN i'27'29'31'32'38'44'52'61. GABA is re- 
leased in a calcium-dependent manner from CN slices t~'56 
and uptake c,,f tritiated GABA has been demonstrated in 
the CN 34'42. l,antophoretic application of GABA inhibits 
neuronal firing in the CN s'24'25'62 and this effect is 
abolished with the GABA antagonist bicuculline 25. 
Receptor binding sites for GABA are present in the 
CN, as binding of the GABA agonist muscimol has been 
demonstrated autoradiographically in the CN at the light 
microscopic level 1334. However, a comparison of the 
distribution of the muscimol binding with that of the 
distribution of GABA and GAD-like immunoreactivity 
in the CN shows some degree of mismatch. In the central 
portions of the ventral CN, where'there is a high density 
of GABA-immunoreactive terminals, a low density of 
[3H]muscimol binding sites was observed. Furthermore, 
recent findings indicate that not only is GABA co- 
localized with glycine in CN cells, fibers and terminals 3°" 
57 (personal observations), but glycine receptor immu- 
noreactivity is seen apposing GABA-immunoreactive 
terminals in the CN 3°. These results raise questions as to 
the correlation between GABA receptors and GABA- 
ergic terminals. With the recent development of mono- 
clonal antibodies to the GABAg/benzodiazepine (BDZ) 
receptor complex ~°'3~'4°'55, it is now possible to study the 
distribution of this receptor complex with great sensitivity 
and resolution. For this study, we have used a monoclo- 
hal antibody against the GABAA/BDZ receptor s5 to 
investigate, at both the light and electron microscopic 
level, the distribution of GABAA/BDZ receptor-like 
immunoreactivity (Ll) in the CN. 
Twelve adult guinea pigs were heavily anesthetized 
with chloral hydrate and perfused intravascularly with 
saline followed by a fixative containing 4% paraformal- 
dehyde and 0.1% glutaraldehyde in 0.1 M cacodylate 
bufter. The brainstem was removed, placed in the same 
fixative for 4 h at 4 °C and washed overnight in cold 
buffer. Sections through the CN of 50 ~tm thickness, 
obtained using an oscillating tissue slicer (Vibratome), 
were incubated for 72 h in the monoclonal antibody 
62-3G11°'55 diluted 1:100 in phosphate-buffered saline 
(PBS). This antibody has been shown to react with a 
57,000 M r (fl) subunit of the GABAA/BDZ receptor 
complex in immunoblots, and its characteristics and 
specificity have been described hi detail ss. The avidin- 
biotin-peroxidase complex (ABC) technique of Hsu et 
al.19 (Vectastain kit, Vector Labs) was used to visualize 
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the immunoreaction product, with diaminobenzidine as 
the chromogen. As a control for the specificity of this 
method, alternate sections were incubated either in 
non-immune mouse serum or in PBS substituted for the 
primary antibody. Sections for light microscopy (LM) 
were mounted onto slides, allowed to dry overnight, 
coverslipped and observed with a Leitz Dialux photomi- 
croscope equipped with differential interference contrast 
optics. Sections for electron microscopy (EM) were 
postfixed in a mixture of 1% osmium tetroxide and 1.5% 
potassium ferricyanide, dehydrated in graded ethanols 
and embedded in EMbed 812 (EMSciences). Sections of 
75-80 nm thickness of the anteroventral (AVCN) and 
dorsal (DCN) cochlear nucleus were observed without 
uranyl acetate or lead citrate counterstaining, using a 
JEOL EM-1200 electron microscope. 
Immunostaining was not observed, either at the LM or 
EM levels, in the control sections of which the incubation 
in primary antibody was omitted. As uranyl acetate and 
lead citrate were not used to counterstain ultrathin 
sections, the synaptic densities were undetectable elec- 
tron microscopically. Thus, it was assumed that the 
labeling observed in the experimental tissue was related 
to the presence of specific immunolabeling. 
Apart from some scattered granule cells in the granule 
cell layer, no immunostaining was evident in the VCN 
(AVCN and PVCN) at the LM level after incubation with 
the 62-3G1 antibody (Fig. la).  In contrast, the DCN 
showed intense GABAA/BDZ receptor-LI, particularly 
in the superficial (molecular and fusiform) layers. Me- 
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Fig. 1. GABAA/benzodiazepine receptor-like immunoreactivity in the cochlear nucleus. The anteroventral (avcn, la) and posteroventral (pvcn, 
lb) cochlear nucleus show only background staining and some red blood cells. No immunolabeled neurons are recognizable. In contrast, heavily 
stained neuronal profiles are evident in the dorsal cochlear nucleus (dcn, lb), specifically in the molecular and fusiform layers (m and f in lc). 
The area boxed in lb is shown enlarged in lc. la: 21x. lb: 21x. lc: 340x. 
dium- and small-sized cell bodies in these layers were 
labeled (Fig. lb,c), as were fusiform cell bodies (Fig. lc). 
Immunoreactive dendritic profiles were also abundant 
(Fig. lc). 
Immunostaining was evident at the EM level in the 
rostral AVCN, despite its lack of visibility at thc LM 
level. GABAA/BDZ receptor-LI was observed in me- 
dium and small caliber dendrites, postsynaptic to termi- 
nals containing oval/pleomorphic vesicles (Fig. 2a,b) and, 
less frequently, in primary dendritic trunks (Fig. 2c). No 
immunoreactivity was seen apposing terminals on spher- 
ical/bushy cell bodies (Fig. 2a), despite the fact that these 
somata have been shown to receive a significant number 
of GABA-iike immunoreactive terminals a°'31"38"44"5°'52'61. 
In the DCN, however, GABAA/BDZ receptor-LI ap- 
posed both axo-somatic (Fig. 3a) and axo-dendritic (Fig. 
3b,c) terminals on fusiform cells. Some of the medium 
and small cells in the molecular and fusiform cell layers 
als0 had GABAA/BDZ receptor-LI apposing terminals 
on both somata and dendrites. While most terminals 
apposing GABAA/BDZ receptor immunolabel contained 
oval/pleomorphic vesicles, some possessed flattened ves- 
icles (Fig. 2c). Occasionally, presynaptic localization of 
the GABAA/BDZ receptor was observed both in DCN 
(Fig. 3a) and AVCN. In both subdivisions, the immuno- 
labeling was always associated with the cytoplasmic side 
of the junctional membrane (Figs. 2a,b,c and 3a,b,c). 
However,  the labeling was not restricted to synaptic 
membranes.  Intense cytoplasmic labeling was also seen 
deep within fusiform and small cell bodies in the DCN 
(Figs. lb ,c  and 3a), as well as in dendritic profiles in both 
AVCN (Fig. 2b) and DCN (Fig. 3c). The immunolabei 
was usually associated with cytoskeletal structures and 
mitochondrial membranes (Figs. 2b and 3a,c). Some 
granule cell bodies and dendrites also contained abun- 
dant cytoplasmic staining. No label was ever found in 
glial cells. 
The present study demonstrates the' existence of 
Fig. 2. Subcellular distribution of the GABAA/benzodiazepine 
receptor-like immunoreactivity in the anteroventrai cochlear nu- 
cleus. The immunoreactivity is found postsynaptic to terminals 
contacting small and medium caliber dendrites (2a, arrowheads and 
2b, synapse 'a') and some primary dendritic trunks (2c, synapse 'b'). 
No immunoreactivity is seen postsynaptic to terminals contacting 
spherical cell bodies (2a, asterisks, sc = spherical cell). Note the 
localization of the immunoreaction product in the cytoplasmic side 
of the postsynaptic membrane and the presence of cytoplasmic 
labeling (2b). Unlabeled synapses in 2a (asterisks) are at the same 
depth of the labeled synapse (arrowheads), relative to the cutting 
surface. In 2b, unlabeled synapses 'b' and 'c' are actually closer to 
the cutting surface than 'a'. Thus, artifacts related to the penetration 
of the antibodies can be safely ruled out. As uranyl acetate and lead 
citrate were not used, there are no postsynaptic densities that could 
be mistakenly interpreted as immunoreactivity (2a, 2b, 2c). Scale 
bars m 2a:200 nm. 2b:400 nm. 2c:250 nm. 
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GABAA/BDZ receptor-LI in the guinea pig CN and adds 
further evidence to support the role of GABA as an 
inhibitory neurotransmitter in the CN. 
The distribution of the immunoreactivity for the 
62-3G1 antibody is heterogeneous. In the superficial 
layers of the DCN, many terminals on both neuronal 
somata and dendrites apposed immunolabeled postsyn- 
. . . . . . . .  • 
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Fig. 3. Subcellular distribution of the GABAA/benzodiazepine 
receptor-like immunoreactivity in the dorsal cochlear nucleus. A 
synapse on a fusiform cell body (3a,fc) shows post- and presynaptic 
immunoreaction product (3a, arrowheads), in the fusiform (3b) and 
molecular (3c) layers, terminals contacting dendrites appose post- 
synaptic immunoreactivity (3b, 'a' ~md 'b'. 3c, arrowheads). Cyto- 
plasmic labeling is also obvious (3a, 3c). In 3b, synapse 'a', which 
is closer to the cutting surfacc, is more intensely stained than 
synapse 'b' (arrowheads). Non eounterstained material. Scale bars 
3a:125 nm. 3b:500 nm. 3c:201) nm. 
aptic membranes. These findings are similar to those 
obtained with other receptor-related antibodies in differ- 
ent areas of the central n e r v o u s  system 2"3"37'53'54'6°. In the 
AVCN, however, GABAA/BDZ receptor-LI was only 
seen apposing some axo-dendritic terminals. None was 
observed apposing axo-somatic terminals on spherical/ 
bushy cells, despite observations that many of the 
terminals contacting these cells exhibit GABA-LI 3°' 
3 1 . 3 8 . 4 4 . 5 0 . 5 2 , 6 1  
Several possibilities exist to explain the finding of a 
heterogeneous localization of the GABAA/BDZ recep- 
tor-LI in the CN and the mismatch with the distribution 
of GABA-LI terminals. It is possible that the structure of 
GABAA/BDZ receptors on spherical/bushy cell bodies is 
different than those on their dendrites, or in DCN cell 
bodies and dendrites. As such they would not be 
recognized by the monoclonal antibody used in this 
study. 62-3G1 recognizes an epitope in the 57,000 M r ~ )  
subunit (GABA/muscimol binding site) of the receptor 
complex ~°'55. In this regard, our results correlate well 
with the distribution of [3H]muscimol binding sites in the 
CN observed in other studies 13'~4. However, the GA- 
BAA/BDZ receptor complex has been shown in other 
areas to exhibit considerable structural heterogeneity as 
demonstrated by differences in ligand binding, photoafo 
finity and immunoaffinity labeling properties 21'a3,3s'36. 
Molecular heterogeneity has also been described using 
recombinant DNA techniques, where the different poly- 
peptide subunits of the receptor complex seem to exhibit 
important variations in their respective primary struc- 
tures 4'22'36'4t. Furthermore, in situ hybridization studies 
indicate a differential distribution in the CNS of the 
mRNAs coding for different subunits of the GABAA/ 
BDZ receptor complex 22'43'46. These results suggest that 
a particular antibody to the GABAA/BDZ receptor 
might not recognize all its forms. How these possible 
structural differences may affect the binding properties of 
the receptor (muscimol binding, for exampte) must be 
addressed in the future. 
The subcellular localization of GABAA/BDZ recep- 
tor-LI (see Figs. 2 and 3) suggests that the antigenic 
determinant recognized by the antibody resides either in 
the cytoplasmic or in the intramembrane domain of the 
,6 subunit. This means that if there are structural 
variations in the GABA~, receptors of the CN (see 
abo ~.'e), this variation resides, at least, in this region(s) of 
the f! subunit. The use of antibodies against other 
epitopes of the GABAA/BDZ receptor 37'4s would be 
helpful to address the extension and location of these 
structural heterogeneities, whose functional role, at 
present, is not clear. 
Another possible explanation for our observations of 
receptor heterogeneity could be that there are GABA- 
ergic terminals not apposed by postsynaptic GABAA/ 
BDZ receptors, but rather by GABA a receptors. 
GABAa receptors are believed to be mainly 
presynaptic 5. However their involvement in postsynaptic 
inhibition has also been proposed 5"~l'28. In the CN, 
Baclofen, an agonist of GABA at GABAa receptors, 
reduces tone-evoked activity 7. Although this effect has 
been linked to inhibition of the release of glutamate and 
aspartate through a presynaptic GABAn receptor 7, the 
presence, distribution and function of postsynaptic GA- 
BAn receptors on CN neurons needs to be determined. 
The availability of GABA antagonists at GABAa 
receptors ~I and the recent development of monoclonal 
antibodies directed against Baclofen ~7 will help to ad- 
dress the question of GABA n receptor localization in the 
CN. 
Regardless of the type (GABAA or GABAa),  our 
results suggest that different subpopulations of GABA 
receptors could be segregated to different receptive 
regions (somata and dendrites) in some neurons. This 
would raise questions regarding the possible functions of 
receptor segregation in terms of auditory signal process- 
ing. Also, a differential receptor distribution between 
somatic and dendritic synapses might be important in 
phenomena involving specific recognition between cells. 
Our observation of GABAA/BDZ label presynaptically 
and its significance also adds to questions deserving 
future study. 
GABAA/BDZ receptor-LI was observed in the cyto- 
plasm of fusiform and small neurons in the DCN. 
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Intracellular labeling has been previously described using 
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neuronal types display more intracellular immunoreac- 
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neurons, using biochemical techniques 9. 
The results of the present study provide further 
evidence of G A B A  receptor heterogeneity in the central 
nervous ~'.ystem, with the additional intriguing suggestion 
of differential localization and segregation of GABA 
receptor types between the soma and dendrites within 
individual neurons. The functional implications of this 
receptor heterogeneity for the processing of auditory 
information remains to be determined. 
The authors are most grateful to Ms. J.M. Bonneau for her expert 
technical assistance. This work was supported by a Generalitat 
Valenciana (Spain) Fellowship to Jos~ M. Juiz and NIH-NIDCD 
Grant NS 24369. 
Drescher (Ed.), Auditory Biochemistry, Charles C. Thomas, 
Springfield, 1985, pp. 198-226. 
9 Cjazowski, C. and Farb, D.H., Transmembrane topology and 
subcellular distribution of the benzodiazepine receptor, J. 
Neurosci., 6 (1986) 2857-2863. 
i0 De Bias, A.L., Vitorica, J. and Friedrich, P., Localization of the 
GABA A receptor in the rat brain with a monoclonal antibody to 
the 57000 M r peptide of the GABAA receptor/benzodiazepine 
receptorlCl channel complex, J. Neurosci., 8, 2 (1988) 602-614. 
11 Dutar, P. and Nicoll, R.A., A physiological role for GABAn 
receptors in the central nervous system, Nature (Lond.), 332 
(198811 i56-158. 
12 Fisher, S.K. and Davies, W.E., GABA and its related enzymes 
in the louver auditory system of the guinea pig, J. Neurochem., 
27 (1976) 1145-1155. 
13 Frostholm, A. and Rotter, A., Autoradiographic localization of 
receptors in the cochlear nucleus of the mouse, Brain Res. Bull., 
16 (1986) 189-203, 
14 Glendenning, K.K. and Baker, B.N., Neuroanatomical distri- 
bution of receptors for three potential inhibitory neurotransmit- 
ters in the bramstem auditory nuclei of the cat, J. Comp. 
Neurol., 275, 2 (1988) 288-308. 
15 Godfrey, D.A., Carter, J.A., Berger, S.J., Lowry, O.H. and 
Matchinsky, EM., Quantitative histochemical mapping of can- 
didate transmitter aminoa~,ds in cat cochlear nucleus, J. Histo- 
chem. Cytochem., 25 (1977) 417-431. 
16 Godfrey, D.A., Carter, J.A., Lowry, O.H. and Matchinsky, 
EM., Distribution of gamma-aminobutyric acid, glycine, gluta- 
mate and aspartate in the cochlear nucleus of the rat, J. 
178 
Histochem. Cytochem., 26 (1978) 118-126. 
17 Holstein, G., Martinelli, G., Zamir, I. and Pasik, P., Visual- 
ization of probable GABA n receptor sites by monoclonal 
anti-baclofen antibodies, Soc. Neurosci. Abstr., 1988, p. 780. 
18 Hughes, T.E., Carey, R.G., Vitorica, J., De Bias, A.L. and 
Karten, H.J., Immunohistochemicai localization of GABA B 
receptors in the retina of the primate Samiri sciureus, Visual 
Neurosc., in press. 
19 Hsu, S.M., Raine, L. and Fanger, H., Use of avidin-biotin- 
peroxidase complex (ABC) and unlabeled antibody (PAP) 
procedures, J. Histochem. Cytochem,, 29 (1981) 577-580. 
20 Jacob, M.H., Lindstrom, J.M. and Berg, D.W., Surface and 
intracellular distribution of a putative neuronal nicotinic acetyl- 
choline receptor, J. Cell Biol., !03 (1986) 205-21-L 
21 Klepner, C.A., Lippa, A.S., Benson, D.I., Sano, M.C. and 
Beer, B., Resolution of two biochemically and pharmacologi- 
cally distinct benzodiazepine receptors, Pharmacol. Biochem. 
Behav., 11 (1979) 456-462. 
22 Levitan, E.S., Schofield, P.R., Burt, D.R., Rhee, L.M., 
Wisden, W., Kohler, M., Fujita, N., Rodriguez, H.E, Stephen- 
son, A. and Darlison, M.G., Structural and functional basis for 
GABA A receptor heterogeneity, Nature (Lond.), 335 (1988) 
76-79. 
23 Mariani, A.P., Cosenza-Murphy, D. and Barker, J.L., GABA- 
ergic synapses and benzodiazepine receptors are not identically 
distributed in the primate retina, Brain Research, 415 (1987) 
153-157. 
24 Martin, M.R., The pharmacology of amino acid receptors and 
synaptic transmission in the cochlear nucleus. In D. Drescher 
(Ed.), Auditory Biochemistry, Charles C. Thompson, Spring- 
field, 1985, pp. 184-197. 
25 Martin, M.R., Dickson, J.W. and Fex, J., Bicuculline, strych- 
nine and depressant aminoacid responses in the anteroventral 
cochlear nucleus of the cat, Neuropharmacology, 21 (1982) 
201-207. 
26 Montpied, P., Martin, B.M., Cottingham, L., Stubblefield, 
B.K., Ginns, E.I. and Paul, S.M., Regional distribution of the 
GABAA/henzodiazepine receptor (alpha subunit) mRNA in rat 
brain, J. Neurochem., 15 (1988) 1651-1654. 
27 Moore, J.K. and Moore, R.Y., Glutamic acid decarboxylase-like 
immunoreactivity in brainstem auditory nuclei of the rat, J. 
Comp. Neurol., 260 (1987) 157-174. 
28 Mort, D,D., Lewis, D.V., Bragdon, A.C. and Wilson, W.A., 
Evidence that depression of recurrent inhibition following 
tetanic stimulation in the rat dentate gyrus is mediated by 
GABAn receptors, Soc. Neurosci. Abstr., 1988, p. 809, 
29 Mugnaini, E., GABA neurons in the superficial layers of the rat 
dorsal cochlear nucleus: light and electron microscopy immuno- 
cytochemistry, J. Comp. Neurol., 235 (1985) 61-81. 
30 Oberdorfer, M.D., Parakkal, M.H., AItschuler, R.A. and 
Wenthold, R.J., Co-localization of glycine and GABA in the 
cochlear nucleus, Soc. Neurosci. Abstr., 1987, p. 544. 
31 Oberdorfer, M.D., Parakkal, M.H., AItschuler, R.A. and 
Wenthold, R.J., Ultrastructural localization of GABA immu- 
noreactive terminals in the anteroventral cochlear nucleus of the 
guinea pig, Hearing Res., 33, 3 (1988) 229-238. 
32 Ottersen, O.P. and Storm-Mathissen, J., Neurons containing or 
accumulatieg transmitter aminoacids. In: Handbook of Chemical 
Neuroanatomy, 3: Classical Transmitters and Transmitter Recep- 
tors in the CNS, Part l, Elsevier, Amsterdam, 1984, pp. 141-246. 
33 Park, D., Vitorica, J. and De Bias, A.L., Molecular heteroge- 
neity of the GABAA/benzodiazepine receptor complex, Soc. 
Neurosci. Abstr., 1988, p. 977. 
34 Potashner, S.J., Lindberg, N. and Morest, D.K., Uptake and 
release of GABA in the guinea pig cochlear nucleus after 
axotomy of cochlear and centrifugal fibers, J. Neurochem., 44 
(1985) 1558-1566. 
35 Pritchett, D.B., Stonheimer, H., Gorman, C,M., Kettenman, 
H., Seeburg, P.H. and Schofield, P.R., Transient expression 
shows ligand gating and a!!osteric potentiation of GABA A 
receptor subunits, Science, 242 (1988) 1306-1308. 
36 Pritchett, D.B., Stonheimer, H., Shivers, B.D., Ymer, S., 
Kettenmann, H., Schofield, P.R. and Seeburg, P.H., Importance 
of a novel GABA A receptor subunit for benzodiazepine phar- 
macology, Nature (Lond.), 338 (1989) 582-585. 
37 Richards, J.G., Schoch, P., Haring, P., Takacs, B. and Mohler, 
H., Resolving GABAA/benzodiazepine receptors: cellular and 
subcellular localization in the CNS with monoclonal antibodies, 
J. Neurosci., 7, 6 (1987) 1866-1886. 
38 Roberts, R.C. and Ribak, C.E., GABAergic neurons and axon 
terminals in the brainstem auditory nuclei of the gerbil, J. Comp. 
Neurol., 258 (1987) 267-280. 
39 Schmidt, J.W. and Catteral, W, A., Biosynthesis and processing 
of the alpha subunit of the voltage-sensitive sodium channel in 
rat brain neurons, Cell, 46 (1986) 437-444. 
40 Schoch, P., Richards, J.G., Haring, P., Takacs, B., Stahli, C., 
Staehelin, T., Haefely, W. and Mohler, H., Co-localization of 
GABA A receptors and benzodiazepine receptors in the brain 
shown by monoclonal antibodies, Nature (Lond.), 314 (1985) 
168-171. 
41 Schofield, P.R., Darlison, M.G., Fujita, N., Burr, D.R., 
Stephenson, EA., Rodriguez, H., Rhee, L.M., Ramachandran, 
J., Reale, V. and Glencorse, T.A., Sequence and functional 
expression of the GABA A receptor shows a ligand-gated 
receptor super family, Nature (Lond.), 328 (1987) 221-227. 
42 Schwartz, I.R., The differential dist~bution of label following 
uptake of H3-1abeled aminoacids in the DCN of the cat, Exp. 
Neurol., 73 (1981) 601-607. 
43 Sequier, J.M., Richards, J.G., Malherbe, P,, Price, G.W., 
Mathews, S. and Mohler, H., Mapping of brain areas containing 
RNA homologous to the cDNAS encoding the alpha and beta 
subunits of the rat GABA A receptor, Proc. Natl. Acad. Sci. 
U.S.A., 85 (1988) 7815-7819. 
44 Shiraisi, T., Senba, E., Tohyama, M., Wu, J., Kubo, T. and 
Matsunaga, T., Distribution and fine structure of neuronal 
elements containing glutamic acid decarboxylase in the rat 
cochlear nucleus, Brain Research, 347 (1985) 183-187. 
45 Sieghart, W. and Karobath, M., Molecular heterogeneity of 
benzodiazepine receptors, Nature (Lond.), 286 (1980) 285-287. 
46 Siegel, R.E., Differential distribution of GABAA/benzodiaze- 
pine receptor subunit mRNAs in the bovine cerebellum, Soc. 
Neurosci. Abstr., 1988, p. 977. 
47 Smith, M.M., Lindstrom, J. and Merlie, J.P., Formation of the 
alpha-bungarotoxin binding site and assembly of the nicotinic 
acetylcholine receptor subunits occur in the endoplasmic reticu- 
lure, J. Biol. Chem., 262 (1987) 4367-4376. 
48 Somogyi, E, Takagi, H., Richards, J.G. and Mohler, H., 
Subcellular localization of benzodiazepine/GABA A receptors in 
the cerebellum of rat, cat and monkey, using monoclonal 
antibodies, J. Neurosci., 9 (1989) 2197-2209. 
49 Swanson, L.W., Simmons, D.M., Whiting, P.J. and Linstrom, 
J., Immunohistochemical localization of neuronal nicotinic 
receptors in the rodent central nervous system, J. Neurosci., 7 
(1987) 3334-3342. 
50 Tachibana, M. and Kuriyama, K., Gamma-aminobutyric acid in 
the lower auditory pathway of the guinea pig, Brain Research, 
69 (1974) 370-374. 
51 Tamkum, M.M. and Fambrough, D.M., The Na+-K + ATP-ase 
of chick sensory neurons. Studies on biosynthesis and intracel- 
lular transport, J. Biol. Chem., 261 (1986) 1009-1119. 
52 Thompson, G.C., Cortex, A.M. and Lam, D.K.M., Localiza- 
tion of GABA immunoreactivity in the auditory brainstem of 
guinea pigs, Brain Research, 339 (1985) 119-122. 
53 Triller, A., Cluzeaud, F., Pfeiffer, F. and Korn, H., Distribution 
of glycine receptors at central synapses: an immunoelectron 
microscopy study, J. Cell Biol., 101 (1985) 683-688. 
54 Van den Pol, A.N. and Gorcs, T., Glycine and glycine receptor 
immunoreactivity in brain and spinal cord, J. Neurosci., 8, 2 
(1988) 472-492. 
55 Vitorica, J., Park, D., Chin, G. and De Bias, A.L., Monoclonal 
antibodies and conventional antisera to the GABA A receptor/ 
benzodiazepine receptor/Cl channel complex, J. Neurosci., 8, 2 
(1988) 615-622. 
56 Wenthold, R.J., Release of endogenous glutamic acid, aspartic 
acid and GABA from cochlear nucleus slices, Brain Research, 
162 (1979) 338-343. 
57 Wenthold, R.J., Huie, D., Aitschuler, R.A. and Reeks, K.A., 
Glycine immunoreactivity localized in the cochlear nucleus and 
superior olivary complex, Neuroscience, 22 (1987) 897-912. 
58 Wenthold, R.J. and Martin, M.R., Neurotransmitters of the 
auditory nerve and central auditory system. In C. Berlin (Ed.), 
Hearing Science, College-Hill Press, San Diego, 1984, pp, 
34!--370. 
59 Wenthold, R.J. and Morest, D.K., Transmitter related enzymes 
in the guinea pig cochlear nucleus, Soc. Neurosci. Abstr., 1976, 
p. 28. 
179 
60 Wenthoid, R.J., Parakkal, M.H., Oberdorfer, M.D. and Alt- 
schuler, R.A., Glycine receptor immunoreactivity in the ventral 
cochlear nucleus of the guinea pig, J. Comp. Neurol., 276 (1988) 
423-435. 
61 Wenthold, R.J., Zempel, J.M., Parakkal, M.H., Reeks, K.A. 
and Altschaier, R.A., Immunocytochemical localization of 
GABA in the cochlear nucleus of the guinea pig, Brain 
Research, 380 (1986) 7-18. 
62 Whitfield, I.C. and Comis, S.D., The role of inhibition in 
information transfer: the interaction of centrifugal and centrip- 
etal stimulation on neurones of the cochlear nucleus, Final 
Report, European Office of Aerospace Research, U.S.A.F., 
1966, Grant 63-115. 
63 Yazulla, S., Studholme, K.M., Vitorica, J. and De Bias, A.L., 
Immunocytochemical localization of GABA A receptors in gold- 
fish and chicken retinas, J. Comp. Neurol, 280 (1989) 15-26. 
